| Literature DB >> 35911030 |
Ana Carolina Paludo1, Armin Paravlic1,2,3, Kristýna Dvořáková4, Marta Gimunová5.
Abstract
This article aimed to investigate the effects of menstrual cycle phases on perceptual responses in athletes by means of systematic review and meta-analysis. The search was conducted in the PubMed, Web of Science, and Sport Discus databases considering articles with two or more menstrual phases for comparison. The PECO criteria were used for the keywords "menstrual cycle," "athletes," and "perceptual responses" with their respective entry terms. Of 1.165 records identified, 14 articles were available for the final evaluation, while eight articles were eligible for a meta-analysis. The perceptual responses evaluated in the studies were: motivation, competitiveness, sleep quality, stress, muscle soreness, fatigue, perceived effort, mood, menstrual symptoms, perceived endurance, and readiness. The meta-analysis was conducted for perceived effort only. The results showed that the level of perceived exertion does not differ two phases of the menstrual cycle (MD = 3.03, Q = 1.58, df = 1, p = 0.209), whereas RPE was 19.81 ± 0.05 and 16.27 ± 0.53 at day 1-5 and day 19-24, respectively. Two studies found statistically significant changes in motivation and competitiveness during the cycle, with better outcomes in ovulatory phase compared to follicular and luteal. One study found an increase in mood disturbance in the pre-menstrual phase (vs. mid-cycle); one decreased vigor in the menstrual phase (vs. luteal); one increased the menstrual symptoms in the follicular phase (vs. ovulation), and one study reported increased fatigue and decreased sleep quality on luteal phase (vs. follicular). The remaining studies and variables were not affected by the menstrual cycle phase. Based on the results from the studies selected, some perceptual responses are affected in different menstrual cycle phases. A "favorable" subjective response in athletes was noticed when the ovarian hormones present an increase in concentration levels compared to phases with lower concentration. Different perceptual variables and methodological approaches limit the generalization of the conclusion.Entities:
Keywords: athletes; behavior; female; menstrual cycle; ovarian hormones
Year: 2022 PMID: 35911030 PMCID: PMC9328165 DOI: 10.3389/fpsyg.2022.926854
Source DB: PubMed Journal: Front Psychol ISSN: 1664-1078
Figure 1Flow chart diagram of the study process (PRISMA 2020).
Sample characteristics, menstrual cycle measurement and perceptual variable.
|
|
|
| ||||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
| Carmichael et al. ( | Elite football players | – |
| F/L | 28 ± 3 | Day control and LH urine test strip | Sleep, stress, soreness and fatigue; RPE | Wellness questionnaire; Borg CR-10 |
| Chaffin et al. ( | Competitive runners |
| 3 months (Participant's documentation) | EF/ML | 30.6 ± 4.6 | Day control, estradiol and progesterone concentrations | Muscle soreness | DOMS rating scale |
| Cockerill et al. ( | Runners | Amenorrhoeic runners ( |
| PM/MC | – | Day control | Mood | POMS–TMD |
| Cook et al. ( | Elite athletes from different sports | Non-elite athletes |
| D7/D14/D21 (3 consecutive cycles) | 24–33 (28.7 ± 1.9) | Day control | Motivation to train | Likert scale 1–7 |
| Crewther and Cook ( | Elite athletes from different sports | Non-elite athletes |
| F/O/L (3 consecutive cycles) | Cycle 1: 27.9 ± 0.8 | Day control | Competitiveness | Likert scale 1–7 |
| Cristina-Souza et al. ( | Track and field athletes |
| 2 months (Participant's documentation) | F/O/L | 29 ± 3 | Day control and hormonal analysis | RPE; MCS | Borg CR10; PMT-A, PMT-C, and PMT-D |
| De Souza et al. ( | Runners | Amenorrhoeic runners | 1 month (LH urine test to determine the ovulatory period) | EF/ML | 23–33 | LH urine test strip | RPE | Borg 6–20 scale |
| Graja et al. ( | Handball players | – | 6 months (menstruation diary) | F/L/PM | – | Day control, urine LH strip | Sleep, fatigue, stress, and soreness | Hooper index |
| Julian et al. ( | High-level soccer players | – | 6 months (menstruation diary) | EF/ML | – | Day control and serum hormones | RPE | Borg 6–20 scale |
| Lara et al. ( | Well-trained triathletes | Placebo vs. caffeine | 4 months (Mobile app Mycalendar) | EF/PO/ML | 27 ± 2 days (24–31 days) | Day control, LH urine test strip | Self-perceived endurance; Exertion | 1–10 scale; Borg 6–20 scale |
| Martínez-Cantó et al. ( | Physically active sport science students | – | 3 months (Participant's documentation) | M/L | 31.20 ± 1.82 | Day control | RPE | Borg CR-10 |
| Miskec et al. ( | College club rugby players | – | 2 months (Participant's documentation) | M/Non-M | – | Day control | RPE | Borg 6–20 scale |
| Rael et al. ( | Well-trained in endurance activities |
| 6 months before the study—regular cycle | EF/LF/ML | 28 ± 2–31 ± 2 | Day control, urinary LH measurement and serum hormone analysis | RPE | Borg 6–20; PR Nurmekivi 1–5 scale |
| Sunderland and Nevill ( | Well-trained game players | OC well-trained game players |
| F/L | 24–30 | Day control | RPE | Borg 6–20 scale |
EF, Early follicular; PO, Preovulation; ML, Mid luteal; LF, Late follicular; PM, Premenstrual; MC, Midclyce; F, Follicular; L, Luteal; MF, Mid follicular; M, Menstrual phase; Non-M, Nonmenstruation; LH, Luteinizing hormone; D7, day 7; D14, day 14; D2, day 21; OC, Oral contraception; RPE, Rating perceived effort; DOMS, Delayed onset muscle soreness; TRIMP, Training impulse; PMT-A(anxiety, nervous tension, irritability, mood changes); PMT-C (craving for sweets, headache, fatigue, fainting spells, palpitations); PMT-D (depression, withdrawal, insomnia, forgetfulness, and confusion); POMS, Profile of mood state; KSD, Karolinska sleep diary; TMD, Total mood disturbance.
Perceptual measure and main outcomes.
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Carmichael et al. ( | ↓L vs. F | ↔ | ↔ | ↑ L vs. F | ↔ | ||||||
| Chaffin et al. ( | ↔ | ||||||||||
| aCockerill et al. ( | ↑PM vs. MC (88.1%) | ||||||||||
| bCook et al. ( | ↑ D14 vs. D7, D2 | ||||||||||
| Crewther and Cook ( | ↑ O vs. F, L | ↑ O vs. F, L ↑ F vs. L | |||||||||
| Cristina-Souza et al. ( | ↔ | ↑F vs. O | |||||||||
| De Souza et al. ( | ↔ | ||||||||||
| Graja et al. ( | ↔ | ↔ | ↔ | ↔ | |||||||
| Julian et al. ( | ↔ | ||||||||||
| Lara et al. ( | ↔ | ↔ | |||||||||
| Martínez-Cantó et al. ( | ↔ | ↔ | ↓M vs. L (vigor) 22.7% | ||||||||
| Miskec et al. ( | ↔ | ||||||||||
| cRael et al. ( | ↔ | ↑ EF vs. LF and ML (6.1%) | |||||||||
| Sunderland and Nevill ( | ↔ |
↑, significant increase/improvement; ↓, significant decrease/impairment; ↔, no significant difference.
.
Figure 2Meta-analysis.